System Transmission

Top Signal

100#1 JOB

Activity

2186Ripe

+957 today

System

Livenow

Terminal Asset View

stockNASDAQ

VYGR

$4.46-8.52%

Voyager Therapeutics Inc

Overripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

50Overripe

Live Analysis Active

Company Mission

Voyager Therapeutics creates gene therapies that target serious neurological conditions like Parkinson's disease and ALS. These therapies work by delivering genetic material to cells to correct or replace faulty genes. The company makes money through research collaborations with larger drug companies and could earn revenue from future drug sales if treatments are approved.

VYG

Industry Context

The biotechnology industry focuses on developing treatments using biological systems. Gene therapy is a growing area within biotech that aims to treat diseases by modifying a person's genes. Companies in this space often partner with larger pharmaceutical firms to fund research and development.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

38Matrix

Market Momentum

57.4— Holding Steady

Trend Strength

75— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

1.2x— Normal Volume

Today's Change

-8.52%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

Gap Exposure-1

Large opening gap indicates potential short-term exhaustion.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing VYGR across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 10:34 AM UTC

As-of 03-15-2026 10:19 UTC

Develops gene therapies that treat neurological diseases and makes money by partnering with drug companies to advance these treatments.

Price has been consolidating in a tight range for several weeks, suggesting energy is building for the next significant move showing consolidation.

Biotech sector showing renewed interest in gene therapy platforms, which could benefit companies with advanced neurological disease programs.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...